ICD Co. Ltd Total Liabilities
ICD Co. Ltd total liabilities. Based on the latest financial reports, ICD Co. Ltd (040910) has total liabilities worth ₩82.45 Billion KRW (≈ $55.87 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are ICD Co. Ltd's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ICD Co. Ltd (2013–2025)
Total liabilities of ICD Co. Ltd from 2013 to 2025. This chart illustrates how ICD Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore 040910 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
ICD Co. Ltd Competitors by Total Liabilities
The table below lists competitors of ICD Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TradeDoubler AB
ST:TRAD
|
Sweden | Skr680.21 Million |
|
Yarrow Bioscience Inc
NASDAQ:YARW
|
USA | $1.24 Million |
|
NK Co. Ltd
KO:085310
|
Korea | ₩54.71 Billion |
|
Ilji Technology Co. Ltd
KQ:019540
|
Korea | ₩454.61 Billion |
|
E-World
KO:084680
|
Korea | ₩190.68 Billion |
|
Chih Lien Industrial Co Ltd
TW:2024
|
Taiwan | NT$495.04 Million |
|
HAV GROUP ASA
F:6HH
|
Germany | €568.81 Million |
|
Nusa Konstruksi Enjiniring Tbk
JK:DGIK
|
Indonesia | Rp763.54 Billion |
Liability Composition Analysis (2013–2025)
This chart breaks down ICD Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 040910 asset base.
Liquidity & Leverage Metrics
ICD Co. Ltd Total Liabilities Ratios Explained
ICD Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ICD Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ICD Co. Ltd (2013–2025)
The table below shows the annual total liabilities of ICD Co. Ltd from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩45.92 Billion ≈ $31.12 Million |
-51.24% |
| 2024-12-31 | ₩94.17 Billion ≈ $63.82 Million |
+18.49% |
| 2023-12-31 | ₩79.47 Billion ≈ $53.86 Million |
+61.35% |
| 2022-12-31 | ₩49.25 Billion ≈ $33.38 Million |
-24.12% |
| 2021-12-31 | ₩64.91 Billion ≈ $43.99 Million |
+21.05% |
| 2020-12-31 | ₩53.63 Billion ≈ $36.34 Million |
-5.45% |
| 2019-12-31 | ₩56.72 Billion ≈ $38.44 Million |
-5.20% |
| 2018-12-31 | ₩59.83 Billion ≈ $40.54 Million |
-41.40% |
| 2017-12-31 | ₩102.09 Billion ≈ $69.18 Million |
-20.56% |
| 2016-12-31 | ₩128.51 Billion ≈ $87.09 Million |
+353.00% |
| 2015-12-31 | ₩28.37 Billion ≈ $19.23 Million |
+50.47% |
| 2013-12-31 | ₩18.85 Billion ≈ $12.78 Million |
-- |
About ICD Co. Ltd
ICD Co., Ltd. engages in the manufacture and sale of AMOLED, LCD, and semiconductor equipment in South Korea and internationally. The company offers DRY etcher and research-thermal evaporator. It also involves in bio and medical business by using plasma to develop devices and products for sterilization, medicine, cosmetics, etc. The company was founded in 2000 and is headquartered in Anseong-si, … Read more